The pharmaceutical industry's ability to innovate and deliver effective treatments hinges on the availability of specialized chemical intermediates. These compounds are the unsung heroes of drug development, enabling the synthesis of complex APIs that form the basis of modern therapies. Among these vital substances is 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene, identified by CAS number 1103738-29-9. This compound is particularly significant as a pharmaceutical intermediate used in the synthesis of Ipragliflozin, a SGLT2 inhibitor vital for managing type 2 diabetes. NINGBO INNO PHARMCHEM CO.,LTD., a prominent pharmaceutical intermediate supplier in China, is at the forefront of providing this high-quality chemical building block.

Delving into the chemical profile of 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene reveals why it is so critical. With a molecular formula of C15H14ClIO and a molecular weight of approximately 372.63 g/mol, this compound is typically supplied as a white or off-white powder, boasting a purity of ≥99.0%. These characteristics are indicative of precise chemical synthesis and rigorous purification processes. Its physical properties, such as a density of 1.531 g/cm³ and a high boiling point of around 411.2 °C, suggest stability and suitability for demanding chemical reactions. These attributes make it an invaluable tool for organic chemists involved in the complex synthesis of pharmaceutical compounds. For those looking to buy 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene, understanding these properties is key to appreciating its value.

The primary application that elevates the importance of 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene is its role in the synthesis of Ipragliflozin. Ipragliflozin targets the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, a mechanism that helps regulate blood glucose levels by increasing urinary glucose excretion. This mechanism is crucial for effective type 2 diabetes management. The intricate structure of Ipragliflozin requires intermediate compounds that can be precisely manipulated through various chemical reactions. 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene provides the necessary framework and reactive sites to facilitate this synthesis, making it a sought-after component for pharmaceutical manufacturers. As a leading 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. ensures the consistent quality and availability of this intermediate.

The reliability of pharmaceutical intermediates directly impacts the efficiency and success of drug development and manufacturing. NINGBO INNO PHARMCHEM CO.,LTD. prides itself on being a dependable pharmaceutical intermediates supplier in China, offering not only high-purity products but also expert support. Our commitment to quality assurance, coupled with our robust manufacturing capabilities, ensures that clients receive intermediates that meet the highest industry standards. By partnering with us, pharmaceutical companies can streamline their supply chains and focus on their core mission of developing innovative treatments. We facilitate the easy procurement of essential chemicals for your R&D and production needs.

In essence, 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene (CAS 1103738-29-9) is a prime example of a crucial pharmaceutical intermediate that underpins advancements in medical treatment. Its meticulous synthesis and high purity are critical for the production of drugs like Ipragliflozin. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being a key enabler in this process, providing the quality and reliability that the pharmaceutical industry demands from its partners in China.